|
Volumn 6, Issue 3, 2014, Pages 518-531
|
Interaction between 8-hydroxyquinoline ruthenium(II) complexes and basic fibroblast growth factors (bFGF): Inhibiting angiogenesis and tumor growth through ERK and AKT signaling pathways
|
Author keywords
[No Author keywords available]
|
Indexed keywords
8-HYDROXYQUINOLINE;
ANTITUMOR EFFECT;
BASIC FIBROBLAST GROWTH FACTOR;
CELL SURFACE RECEPTORS;
RUTHENIUM COMPLEXES;
SIGNALING CASCADES;
SIGNALING PATHWAYS;
SPECIFIC INHIBITORS;
CELL DEATH;
CELL MEMBRANES;
CELL PROLIFERATION;
ENDOTHELIAL CELLS;
RUTHENIUM;
TUMORS;
RUTHENIUM COMPOUNDS;
8 HYDROXYQUINOLINE RUTHENIUM II COMPLEX;
[RU(BPY) 2 (8 HYDROXYQUINOLINE)];
[RU(PHEN) 2 (8 HYDROXYQUINOLINE)];
ANTINEOPLASTIC AGENT;
CASPASE 3;
CASPASE 8;
CASPASE 9;
CELL SURFACE RECEPTOR;
FIBROBLAST GROWTH FACTOR 2;
MITOGEN ACTIVATED PROTEIN KINASE;
PROTEIN KINASE B;
REACTIVE OXYGEN METABOLITE;
RUTHENIUM DERIVATIVE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIANGIOGENIC ACTIVITY;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
ARTICLE;
CANCER INHIBITION;
CELL INVASION;
CELL PROLIFERATION;
CELL STRAIN HEPG2;
CONTROLLED STUDY;
CYTOTOXICITY ASSAY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ELECTROSPRAY MASS SPECTROMETRY;
ENDOTHELIUM CELL;
ENZYME ACTIVITY;
HUMAN;
HUMAN CELL;
MIGRATION INHIBITION;
MITOCHONDRIAL MEMBRANE POTENTIAL;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN INTERACTION;
PROTON NUCLEAR MAGNETIC RESONANCE;
RECEPTOR BINDING;
SIGNAL TRANSDUCTION;
TUMOR MODEL;
TUMOR VOLUME;
UMBILICAL VEIN ENDOTHELIAL CELL;
ANGIOGENESIS INHIBITORS;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CELL MOVEMENT;
CELL PROLIFERATION;
COORDINATION COMPLEXES;
FIBROBLAST GROWTH FACTOR 2;
HEP G2 CELLS;
HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS;
HUMANS;
MALE;
MAP KINASE SIGNALING SYSTEM;
MICE;
MICE, SCID;
NEOPLASMS;
OXYQUINOLINE;
PROTO-ONCOGENE PROTEINS C-AKT;
RUTHENIUM;
SIGNAL TRANSDUCTION;
|
EID: 84896811855
PISSN: 17565901
EISSN: 1756591X
Source Type: Journal
DOI: 10.1039/c3mt00237c Document Type: Article |
Times cited : (63)
|
References (39)
|